• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis.

作者信息

Carter Melody C, Robyn Jamie A, Bressler Peter B, Walker John C, Shapiro Gail G, Metcalfe Dean D

出版信息

J Allergy Clin Immunol. 2007 Jun;119(6):1550-1. doi: 10.1016/j.jaci.2007.03.032. Epub 2007 May 3.

DOI:10.1016/j.jaci.2007.03.032
PMID:17481708
Abstract
摘要

相似文献

1
Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis.奥马珠单抗用于治疗系统性肥大细胞增多症患者的不明原因过敏反应。
J Allergy Clin Immunol. 2007 Jun;119(6):1550-1. doi: 10.1016/j.jaci.2007.03.032. Epub 2007 May 3.
2
Successful treatment of idiopathic anaphylaxis in an adolescent.一名青少年特发性过敏反应的成功治疗
J Allergy Clin Immunol. 2010 Aug;126(2):415-6; author reply 416. doi: 10.1016/j.jaci.2010.05.043. Epub 2010 Jul 10.
3
Omalizumab induced remission of idiopathic anaphylaxis in a patient suffering from indolent systemic mastocytosis.奥马珠单抗使一名患有惰性系统性肥大细胞增多症的患者的特发性过敏反应得到缓解。
Acta Derm Venereol. 2014 May;94(3):363-4. doi: 10.2340/00015555-1687.
4
Omalizumab monotherapy for bee sting and unprovoked "anaphylaxis" in a patient with systemic mastocytosis and undetectable specific IgE.奥马珠单抗单药治疗系统性肥大细胞增多症且特异性IgE检测不到的患者的蜂蜇伤和不明原因的“过敏反应”
Ann Allergy Asthma Immunol. 2010 Jun;104(6):537-9. doi: 10.1016/j.anai.2010.04.011.
5
Prevention of anaphylaxis related to mast cell activation syndrome with omalizumab.使用奥马珠单抗预防与肥大细胞活化综合征相关的过敏反应。
Ann Allergy Asthma Immunol. 2012 May;108(5):383-4. doi: 10.1016/j.anai.2012.02.021. Epub 2012 Mar 21.
6
Omalizumab is effective in treating systemic mastocytosis in a nonatopic patient.奥马珠单抗对一名非特应性患者的系统性肥大细胞增多症治疗有效。
Allergy. 2010 Jul;65(7):926-7. doi: 10.1111/j.1398-9995.2009.02259.x. Epub 2009 Nov 4.
7
Twelve-year follow-up of omalizumab therapy for anaphylaxis in 2 patients with systemic mastocytosis.2例系统性肥大细胞增多症患者接受奥马珠单抗治疗过敏性反应的12年随访
J Allergy Clin Immunol Pract. 2019 Apr;7(4):1314-1316. doi: 10.1016/j.jaip.2018.07.041. Epub 2018 Aug 24.
8
Successful treatment of mastocytic anaphylactic episodes with reduction of skin mast cells after anti-IgE therapy.抗IgE治疗后肥大细胞性过敏反应发作得到成功治疗，皮肤肥大细胞数量减少。
Eur Ann Allergy Clin Immunol. 2013 Apr;45(2):52-5.
9
Systemic mastocytosis presenting as IgE-mediated food-induced anaphylaxis: A report of two cases.表现为IgE介导的食物诱导性过敏反应的系统性肥大细胞增多症：两例报告
J Allergy Clin Immunol Pract. 2015 May-Jun;3(3):456-8. doi: 10.1016/j.jaip.2015.01.011. Epub 2015 Feb 14.
10
Severe anaphylaxis to bee venom immunotherapy: efficacy of pretreatment and concurrent treatment with omalizumab.蜂毒免疫疗法严重过敏反应：奥马珠单抗预处理及联合治疗的疗效
J Investig Allergol Clin Immunol. 2009;19(3):225-9.

引用本文的文献

1
Innovative Therapeutic Approaches in Systemic Mastocytosis: an Updated Review.系统性肥大细胞增多症的创新治疗方法：最新综述
Maedica (Bucur). 2025 Jun;20(2):342-352. doi: 10.26574/maedica.2025.20.2.342.
2
New Indications of Biological Drugs in Allergic and Immunological Disorders: Beyond Asthma, Urticaria, and Atopic Dermatitis.生物药物在过敏性和免疫性疾病中的新适应症：超越哮喘、荨麻疹和特应性皮炎。
Biomedicines. 2023 Jan 17;11(2):236. doi: 10.3390/biomedicines11020236.
3
Successful treatment with Omalizumab of a child affected by Systemic Mastocytosis: clinical and biological implications.
奥马珠单抗成功治疗系统性肥大细胞增多症患儿：临床和生物学意义。
Ital J Pediatr. 2023 Jan 13;49(1):6. doi: 10.1186/s13052-022-01402-7.
4
Target Therapies for Systemic Mastocytosis: An Update.系统性肥大细胞增多症的靶向治疗：最新进展
Pharmaceuticals (Basel). 2022 Jun 11;15(6):738. doi: 10.3390/ph15060738.
5
Omalizumab for prevention of anaphylactic episodes in a patient with severe mosquito allergy.奥马珠单抗用于预防一名严重蚊虫过敏患者的过敏反应发作。
Clin Case Rep. 2021 Oct 21;9(10):e04935. doi: 10.1002/ccr3.4935. eCollection 2021 Oct.
6
Mastocytosis and Mast Cell Activation Disorders: Clearing the Air.肥大细胞增多症和肥大细胞激活障碍：澄清问题。
Int J Mol Sci. 2021 Oct 19;22(20):11270. doi: 10.3390/ijms222011270.
7
Case Report: Mastocytosis: The Long Road to Diagnosis.病例报告：肥大细胞增多症：漫长的诊断之路。
Front Immunol. 2021 Feb 12;12:635909. doi: 10.3389/fimmu.2021.635909. eCollection 2021.
8
Long-Term Successful Treatment of Indolent Systemic Mastocytosis With Omalizumab.奥马珠单抗对惰性系统性肥大细胞增多症的长期成功治疗
Fed Pract. 2021 Jan;38(1):44-48. doi: 10.12788/fp.0081.
9
A Challenge for Allergologist: Application of Allergy Diagnostic Methods in Mast Cell Disorders.过敏学家面临的挑战：在肥大细胞疾病中应用过敏诊断方法。
Int J Mol Sci. 2021 Feb 1;22(3):1454. doi: 10.3390/ijms22031454.
10
Efficacy of Omalizumab in Indolent Systemic Mastocytosis.奥马珠单抗治疗惰性系统性肥大细胞增多症的疗效
Case Rep Hematol. 2019 Sep 16;2019:3787586. doi: 10.1155/2019/3787586. eCollection 2019.